Bilaketaren emaitzak - Jeff B. Smaill

Tissue Pharmacokinetic Properties and Bystander Potential of Hypoxia-Activated Prodrug CP-506 by Agent-Based Modelling nork Victoria Jackson-Patel, Victoria Jackson-Patel, Emily Liu, Matthew R. Bull, Matthew R. Bull, Amir Ashoorzadeh, Amir Ashoorzadeh, Gib Bogle, Gib Bogle, Anna Wolfram, Kevin O. Hicks, Kevin O. Hicks, Jeff B. Smaill, Jeff B. Smaill, Adam V. Patterson, Adam V. Patterson

Connect to this object online.

Interrogation of the Structure-Activity Relationship of a Lipophilic Nitroaromatic Prodrug Series Designed for Cancer Gene Therapy Applications nork Amir Ashoorzadeh, Alexandra M. Mowday, Christopher P. Guise, Shevan Silva, Matthew R. Bull, Maria R. Abbattista, Janine N. Copp, Elsie M. Williams, David F. Ackerley, Adam V. Patterson, Jeff B. Smaill

Connect to this object online.

Restoring Tumour Selectivity of the Bioreductive Prodrug PR-104 by Developing an Analogue Resistant to Aerobic Metabolism by Human Aldo-Keto Reductase 1C3 nork Maria R. Abbattista, Amir Ashoorzadeh, Christopher P. Guise, Alexandra M. Mowday, Rituparna Mittra, Shevan Silva, Kevin O. Hicks, Matthew R. Bull, Victoria Jackson-Patel, Xiaojing Lin, Gareth A. Prosser, Neil K. Lambie, Gabi U. Dachs, David F. Ackerley, Jeff B. Smaill, Adam V. Patterson

Connect to this object online.